1. Sharma VK, Sethuraman G, Kumar B. Cutaneous adverse drug reactions: clinical pattern and causative agents--a 6 year series from Chandigarh, India. J Postgrad Med. 2001;47:95–9.
2. Zou LP, Ding CH, Song ZJ, Li XF. Stevens-Johnson syndrome induced by levetiracetam. Seizure. 2012;21:823–5.
3. Hall DJ, Fromm JS. Drug reaction with eosinophilia and systemic syndrome in a patient taking phenytoin and levetiracetam: a case report. J Med Case Rep. 2013;7:2
4. Duong TA, Haddad C, Valeyrie-Allanore L, Sbidian E, Chosidow O, Wolkenstein P. Levetiracetam: a possible new inducer of toxic epidermal necrolysis and Stevens-Johnson syndrome in 2 cases. JAMA Dermatol. 2013;149:113–5.
5. FDA Approved Labeling text dated 16 Dec 2011. Reference ID: 3060029, www.fda.gov/downloads/Drugs/DrugSafety/UCM152832.pdf.
6. Chung WH, Hung SI, Hong HS, et al. Medical genetics: a marker for Stevens-Johnson syndrome. Nature. 2004;428:486
7. McCormack M, Alfirevic A, Bourgeois S, et al. HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans. N Engl J Med. 2011;364:1134–43.
8. Rajalingam R, Krausa P, Shilling HG, et al. Distinctive KIR and HLA diversity in a panel of north Indian Hindus. Immunogenetics. 2002;53:1009–19.
9. Rani R, Marcos C, Lazaro AM, Zhang Y, Stastny P. Molecular diversity of HLA-A, -B and -C alleles in a North Indian population as determined by PCR-SSOP. Int J Immunogenet. 2007;34:201–8.
10. Koklu E, Ariguloglu EA, Koklu S. Levetiracetam-Induced anaphylaxis in a neonate. Pediatr Neurol. 2014;50:192–4.
11. Alkhotani A, McLachlan RS. Levetiracetam induced angioedema in a patient with previous anticonvulsant hypersensitivity reaction to phenytoin and lamotrigine. Seizure. 2012;21:407–8.
12. Eleni K. Dress syndrome induced by levetiracetam. J Eur Acad Dermatol Venereol. 2015;29:377–8.
13. Jones RT, Evans W, Mersfelder TL, Kavanaugh K. Rare red rashes: a case report of levetiracetam-Induced cutaneous reaction and review of the literature. Am J Ther J. 2016;23:e944–6.
14. Zou X, Hong Z, Zhou D. Hair loss with levetiracetam in five patients with epilepsy. Seizure. 2014;23:158–60.
15. Bhoi Sk, Kalita J, Misra Uk. Skin rash following levetiracetam. Seizure. 2016;37:45–7.
16. Mbizvo GK, Dixon P, Hutton JL, Marson AG. The adverse effect profile of levetiracetam in epilepsy: a more detailed look. Int J Neurosci. 2014;124:627–34.
17. Cheung YK, Cheng SH, Chan EJ, Lo SV, Ng MH, Kwan P. HLA-B alleles associated with severe cutaneous reactions to antiepileptic drugs in Han Chinese. Epilepsia. 2013;54:1307–14.
18. Genin E, Chen DP, Hung SI, et al. HLA-A*31:01 and different types of carbamazepine-induced severe cutaneous adverse reactions: an international study and meta-analysis. Pharmacogenomics J. 2014;14:281–8.
19. Li X, Yu K, Mei S, et al. HLA-B*15:02 increases the risk of phenytoin or lamotrigine induced Stevens-Johnson Syndrome/toxic epidermal necrolysis: evidence from a meta-analysis of nine case-control studies. Drug Res (Stuttg). 2015;65:107–11.
20. Hu FY, Wu XT, An DM, Yan B, Stefan H, Zhou D. Pilot-association study of oxcarbazepine-induced mild cutaneous reaction with HLA B*1502 allele in Chinese Han population. Seizure. 2011;20:160–2.
21. He N, Min FL, Shi YW, et al. Cutaneous reactions induced by oxcarbazepine in Southern Han Chinese: incidence, features, risk factors and relation to HLA-B alleles. Seizure. 2012;21:614–8.
22. Aggarwal R, Sharma M, Modi M, Garg VK, Salaria M. HLA-B* 1502 is associated with carbamazepine induced Stevens–Johnson syndrome in North Indian population. Human Immunol. 2014;75:1120–2.
23. Khor AH, Lim KS, Tan CT, Wong SM, Ng CC. HLA-B*15:02 association with carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in an Indian population: a pooled-data analysis and meta-analysis. Epilepsia. 2014;55:e120–4.
24. Wang XQ, Lv B, Wang HF, et al. Lamotrigine induced DIHS/DRESS: Manifestations, treatment, and outcome in 57 patients. Clin Neurol Neurosurg. 2015;138:1–7.
25. Hu FY, Wang W, Ren JC, An DM, Chen JN, Zhou D. Levetiracetam-induced cutaneous adverse drug reactions were not associated with HLA genes in a small sample of Chinese patients with epilepsy. Epilepsy Res. 2016;124:12–5.